TTR and amyloidosis: Due to the diverse roles and interactions of TTR, its status as a biomarker received much attention, and, in fact, an increasing number of reports strongly suggested ATTR as a potential leading biomarker for ATTRwt and ATTRv amyloidoses and euthyroid hyperthyroxinemia [30,41,42,43,63,69].